https://www.cslbehring.se/ 1.0000 2025-10-20 https://www.cslbehring.se/global-selector 0.5000 2025-07-28 https://www.cslbehring.se/vart-foretag 0.5000 2025-04-10 https://www.cslbehring.se/patienter 0.5000 2025-02-28 https://www.cslbehring.se/forskning-och-utveckling 0.5000 2024-01-08 https://www.cslbehring.se/produkter 0.5000 2025-04-16 https://www.cslbehring.se/factsforu-sjukvardspersonal 0.5000 2025-04-14 https://www.cslbehring.se/play 0.5000 2025-12-04 https://www.cslbehring.se/pressmeddelanden 0.5000 2024-11-13 https://www.cslbehring.se/stories 0.5000 2024-11-13 https://www.cslbehring.se/kontakta 0.5000 2024-01-08 https://www.cslbehring.se/integritetsmeddelande 0.5000 2025-02-28 https://www.cslbehring.se/anvandarvillkor 0.5000 2024-11-05 https://www.cslbehring.se/iceland-information 0.5000 2024-11-05 https://www.cslbehring.se/nordiska-lander 0.5000 2025-07-28 https://www.cslbehring.se/rapportera-en-biverkning 0.5000 2025-05-13 https://www.cslbehring.se/webbplatsoversikt 0.5000 2024-11-05 https://www.cslbehring.se/search 0.5000 2024-11-05 https://www.cslbehring.se/cookie-policy 0.5000 2024-11-05 https://www.cslbehring.se/tillganglighetsforklaring 0.5000 2024-11-05 https://www.cslbehring.se/vart-foretag/ledarskap 0.5000 2026-02-13 https://www.cslbehring.se/vart-foretag/efpia-disclosure-code 0.5000 2023-10-27 https://www.cslbehring.se/vart-foretag/karriar 0.5000 2026-02-09 https://www.cslbehring.se/patienter/hitta-din-sjukdom 0.5000 2024-01-08 https://www.cslbehring.se/patienter/a1rtime 0.5000 2024-10-09 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom 0.5000 2025-04-10 https://www.cslbehring.se/patienter/hitta-din-sjukdom/immunbrist-och-autoimmuna-sjukdomar 0.5000 2025-05-14 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar 0.5000 2025-04-13 https://www.cslbehring.se/patienter/hitta-din-sjukdom/hereditart-angioodem 0.5000 2025-03-06 https://www.cslbehring.se/patienter/hitta-din-sjukdom/alfa-1-antitrypsinbrist 0.5000 2024-11-14 https://www.cslbehring.se/patienter/hitta-din-sjukdom/immunbrist-och-autoimmuna-sjukdomar/primar-immunbrist 0.5000 2025-05-09 https://www.cslbehring.se/patienter/hitta-din-sjukdom/immunbrist-och-autoimmuna-sjukdomar/sekundar-immunbrist 0.5000 2024-11-13 https://www.cslbehring.se/patienter/hitta-din-sjukdom/immunbrist-och-autoimmuna-sjukdomar/cidp 0.5000 2025-05-14 https://www.cslbehring.se/patienter/hitta-din-sjukdom/immunbrist-och-autoimmuna-sjukdomar/itp 0.5000 2025-05-14 https://www.cslbehring.se/patienter/hitta-din-sjukdom/immunbrist-och-autoimmuna-sjukdomar/gbs 0.5000 2025-05-14 https://www.cslbehring.se/patienter/hitta-din-sjukdom/immunbrist-och-autoimmuna-sjukdomar/kawasaki 0.5000 2025-05-14 https://www.cslbehring.se/patienter/hitta-din-sjukdom/immunbrist-och-autoimmuna-sjukdomar/mmn 0.5000 2025-05-14 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/hemofili-a 0.5000 2024-11-13 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/genterapi-vid-hemofili 0.5000 2024-08-30 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/hemofili-b 0.5000 2024-11-13 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/faktor-x 0.5000 2024-11-13 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/bleeding-and-bruising 0.5000 2024-11-13 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/faktor-xiii 0.5000 2024-11-13 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/fibrinogenbrist 0.5000 2024-11-13 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/kvinnor-med-blodningssjukdom 0.5000 2025-03-27 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/genterapi-vid-hemofili/en-introduktion-till-hemofili 0.5000 2024-08-30 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/genterapi-vid-hemofili/en-introduktion-till-genterapi 0.5000 2024-08-30 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/genterapi-vid-hemofili/genterapi-vid-hemofili-en-overblick 0.5000 2024-08-30 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/genterapi-vid-hemofili/vad-ar-genterapi 0.5000 2024-10-09 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/genterapi-vid-hemofili/genterapi-vid-hemofili-sa-fungerar-det 0.5000 2024-08-30 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/genterapi-vid-hemofili/vad-kan-jag-forvanta-mig-under-en-behandling-med-genterapi 0.5000 2024-08-30 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/genterapi-vid-hemofili/hur-langt-har-genterapin-kommit-inom-hemofili 0.5000 2024-08-30 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/genterapi-vid-hemofili/sa-far-du-mer-information 0.5000 2024-08-30 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/genterapi-vid-hemofili/ordlista 0.5000 2024-11-13 https://www.cslbehring.se/patienter/hitta-din-sjukdom/blodningsjukdomar/kvinnor-med-blodningssjukdom/nordisk-studie-om-kvinnor-med-blodningsrubbningar 0.5000 2024-08-30 https://www.cslbehring.se/patienter/hitta-din-sjukdom/hereditart-angioodem/vad-ar-hae 0.5000 2026-02-03 https://www.cslbehring.se/patienter/hitta-din-sjukdom/hereditart-angioodem/hur-paverkar-hae-ditt-liv 0.5000 2026-02-03 https://www.cslbehring.se/patienter/hitta-din-sjukdom/hereditart-angioodem/hantering-av-hae 0.5000 2026-02-03 https://www.cslbehring.se/patienter/hitta-din-sjukdom/hereditart-angioodem/att-leva-med-hae 0.5000 2026-01-30 https://www.cslbehring.se/patienter/hitta-din-sjukdom/hereditart-angioodem/rad-till-foraldrar-med-barn-som-har-hae 0.5000 2026-01-30 https://www.cslbehring.se/patienter/a1rtime/when-should-you-test-for-alpha-1-antitrypsin-deficiency 0.5000 2024-08-30 https://www.cslbehring.se/patienter/a1rtime/the-physically-active-non-smoker-can-also-have-an-alpha-1-antitrypsin-deficiency 0.5000 2024-08-30 https://www.cslbehring.se/patienter/a1rtime/videocast-helene-are-you-ill-or-just-a-carrier-of-alpha-1 0.5000 2024-08-30 https://www.cslbehring.se/patienter/a1rtime/karen-went-to-germany-and-was-given-10-extra-years 0.5000 2024-08-30 https://www.cslbehring.se/patienter/a1rtime/bounced-between-different-hospitals 0.5000 2024-08-30 https://www.cslbehring.se/patienter/a1rtime/early-diagnosis-offers-better-treatment-options 0.5000 2024-08-30 https://www.cslbehring.se/patienter/a1rtime/the-complete-fascination-of-a-protein 0.5000 2024-08-30 https://www.cslbehring.se/patienter/a1rtime/the-long-road-to-diagnosis 0.5000 2024-08-30 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/introduktion-till-von-willebrands-sjukdom 0.5000 2024-10-09 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/arftlighet 0.5000 2024-11-13 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/ordlista 0.5000 2024-11-13 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/var-kan-man-fa-mer-information 0.5000 2024-08-30 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/symtom 0.5000 2025-02-03 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/diagnos 0.5000 2025-01-28 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/leva-med-von-willebrands-sjukdom 0.5000 2024-08-30 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/var-kan-man-fa-mer-information/barnbok-om-von-willebrands-sjukdom 0.5000 2024-08-30 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/var-kan-man-fa-mer-information/blodigt-varre-podd-om-blodarsjuka 0.5000 2024-08-30 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/leva-med-von-willebrands-sjukdom/graviditet-och-forlossning 0.5000 2024-08-30 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/leva-med-von-willebrands-sjukdom/lakemedel-som-ska-undvikas 0.5000 2024-08-30 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/leva-med-von-willebrands-sjukdom/traning-motion-och-halsa 0.5000 2024-08-30 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/leva-med-von-willebrands-sjukdom/forskola-och-skola 0.5000 2024-11-13 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/leva-med-von-willebrands-sjukdom/yrkesval 0.5000 2024-11-13 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/leva-med-von-willebrands-sjukdom/forsakringar 0.5000 2024-11-13 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/leva-med-von-willebrands-sjukdom/riskkort-blodningsrisk 0.5000 2024-11-13 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/leva-med-von-willebrands-sjukdom/resor 0.5000 2024-11-13 https://www.cslbehring.se/patienter/allt-om-von-willebrands-sjukdom/leva-med-von-willebrands-sjukdom/att-leva-ett-normalt-liv 0.5000 2024-08-30 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden 0.5000 2024-11-13 https://www.cslbehring.se/factsforu-sjukvardspersonal/forskningsstod-och-stipendier 0.5000 2024-12-02 https://www.cslbehring.se/factsforu-sjukvardspersonal/produktlista 0.5000 2025-04-16 https://www.cslbehring.se/factsforu-sjukvardspersonal/play 0.5000 2026-02-04 https://www.cslbehring.se/factsforu-sjukvardspersonal/bestall-material 0.5000 2024-11-13 https://www.cslbehring.se/factsforu-sjukvardspersonal/anmalan-till-nyheter 0.5000 2024-11-13 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/immunologi-neurologi 0.5000 2024-10-28 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hematologi 0.5000 2025-10-10 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/alfa-1-antitrypsinbrist 0.5000 2024-11-05 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem 0.5000 2025-04-10 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hematologi/kvinnor-med-blodningssjukdomar 0.5000 2025-03-06 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/what-is-hae 0.5000 2026-02-03 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/the-burden-of-hae 0.5000 2026-02-02 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/goals-of-hae-treatment-and-available-treatment-options 0.5000 2026-02-02 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/considerations-for-special-patient-populations 0.5000 2026-02-02 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/vad-ar-hae 0.5000 2024-11-13 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/testning-och-diagnos 0.5000 2024-08-30 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/behandling-berinert 0.5000 2024-08-30 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/webbinarium 0.5000 2024-11-13 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/invitation-a-csl-sponsored-webinar 0.5000 2025-11-12 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/vad-ar-hae/orsak 0.5000 2024-11-13 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/vad-ar-hae/arftlighet 0.5000 2024-11-13 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/vad-ar-hae/symtom 0.5000 2024-11-13 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/vad-ar-hae/utlosande-faktorer 0.5000 2024-11-13 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/vad-ar-hae/forekomst-och-symtomdebut 0.5000 2024-08-30 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/vad-ar-hae/hae-utlosande-faktorer 0.5000 2025-02-28 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/vad-ar-hae/hae-forekomst-och-symtomdebut 0.5000 2025-02-28 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/testning-och-diagnos/anamnes 0.5000 2024-10-09 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/testning-och-diagnos/testning 0.5000 2024-11-13 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/testning-och-diagnos/atgarder 0.5000 2021-11-18 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/testning-och-diagnos/differentialdiagnoser 0.5000 2021-11-18 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/behandling-berinert/beredningsformer 0.5000 2024-08-30 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/behandling-berinert/effekt 0.5000 2024-10-09 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/behandling-berinert/sakerhetsprofil 0.5000 2024-10-09 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/invitation-a-csl-sponsored-webinar/notification-form 0.5000 2025-11-12 https://www.cslbehring.se/factsforu-sjukvardspersonal/vara-terapiomraden/hereditart-angioodem/invitation-a-csl-sponsored-webinar/notification-form/thank-you 0.5000 2025-11-12 https://www.cslbehring.se/factsforu-sjukvardspersonal/forskningsstod-och-stipendier/csl-behring-nordic-scholarship-for-immunodeficiencies 0.5000 2026-02-25 https://www.cslbehring.se/factsforu-sjukvardspersonal/forskningsstod-och-stipendier/investigator-initiated-studies 0.5000 2025-03-24 https://www.cslbehring.se/factsforu-sjukvardspersonal/forskningsstod-och-stipendier/nordic-vw-scholarship 0.5000 2025-09-18 https://www.cslbehring.se/factsforu-sjukvardspersonal/anmalan-till-nyheter/fel 0.5000 2024-02-01 https://www.cslbehring.se/factsforu-sjukvardspersonal/anmalan-till-nyheter/tack 0.5000 2024-02-01 https://www.cslbehring.se/factsforu-sjukvardspersonal/anmalan-till-nyheter/tack2 0.5000 2024-02-01 https://www.cslbehring.se/stories/story-3 0.5000 2025-02-28 https://www.cslbehring.se/iceland-information/iceland-privacy-notice-for-customer-communication 0.5000 2024-11-13